Dominic Oliver
Early Psychosis: Interventions and Clinical-detection (EPIC) lab,
Department of Psychosis Studies,
Institute of Psychiatry,
Psychology & Neuroscience,
Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience
King's College London
Dominic is a PhD student at the Institute of Psychiatry, King’s College London, under the supervision of Dr Paolo Fusar-Poli and Professor Philip McGuire. Dominic’s research interests involve finding better ways to identify people at risk for psychosis and the interplay between psychosis risk and cannabis. His current studies investigate: a) environmental risk factors for psychosis and, b) different ratios of CBD:THC to find the optimum ratio that reduces the harmful effects of cannabis
Before joining the Institute of Psychiatry, Psychology and Neuroscience, Dominic completed an MSc in Cognitive Neuroscience at University College London before working as a research assistant in the Social Neuroscience lab at the Institute of Cognitive Neuroscience, University College London.
Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.
Schizophrenia bulletin 02, 2018 | Pubmed ID: 28521060
A systematic review and meta-analysis of mental health service use in people who report psychotic experiences.
Early intervention in psychiatry 06, 2018 | Pubmed ID: 28805304
What causes psychosis? An umbrella review of risk and protective factors.
World psychiatry : official journal of the World Psychiatric Association (WPA) Feb, 2018 | Pubmed ID: 29352556
Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.
Schizophrenia bulletin 10, 2018 | Pubmed ID: 29373755
Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction.
European psychiatry : the journal of the Association of European Psychiatrists 03, 2018 | Pubmed ID: 29413807
Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions.
European psychiatry : the journal of the Association of European Psychiatrists 08, 2018 | Pubmed ID: 29787962
Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust.
Schizophrenia bulletin 04, 2019 | Pubmed ID: 29897527
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 06, 2019 | Pubmed ID: 30626906
Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services.
European psychiatry : the journal of the Association of European Psychiatrists 04, 2019 | Pubmed ID: 30658277
Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology May, 2019 | Pubmed ID: 30928180
Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol.
Frontiers in psychiatry , 2019 | Pubmed ID: 30949070
Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes.
Frontiers in psychiatry , 2019 | Pubmed ID: 31057431
What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors.
Schizophrenia bulletin Jun, 2019 | Pubmed ID: 31219164
How experimental cannabinoid studies will inform the standardized THC unit.
Addiction (Abingdon, England) Feb, 2020 | Pubmed ID: 32022348
Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey.
Early intervention in psychiatry Feb, 2020 | Pubmed ID: 32067369
Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.
The lancet. Psychiatry May, 2020 | Pubmed ID: 32220288
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Apr, 2020 | Pubmed ID: 32268347
Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study.
Schizophrenia research Apr, 2020 | Pubmed ID: 32340785
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Tao Wang1,
Dominic Oliver2,
Yamiko Msosa1,
Craig Colling3,
Giulia Spada2,
Łukasz Roguski4,
Amos Folarin1,
Robert Stewart3,5,
Angus Roberts1,3,
Richard J. B. Dobson1,3,4,6,
Paolo Fusar-Poli2,3,7,8
1Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London,
2Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London,
3National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley National Health Service (NHS) Foundation Trust,
4Institute of Health Informatics, University College London,
5Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London,
6Health Data Research UK London, University College London,
7OASIS service, South London and Maudsley National Health Service (NHS) Foundation Trust,
8Department of Brain and Behavioral Sciences, University of Pavia
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved